Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqCM - Nasdaq Real Time Price USD

Jin Medical International Ltd. (ZJYL)

Compare
0.6503
-0.0925
(-12.45%)
At close: April 2 at 4:00:01 PM EDT
Loading Chart for ZJYL
  • Previous Close 0.7428
  • Open 0.7255
  • Bid 0.6254 x 200
  • Ask 0.6945 x 100
  • Day's Range 0.6000 - 0.7550
  • 52 Week Range 0.5900 - 4.6500
  • Volume 543,544
  • Avg. Volume 275,495
  • Market Cap (intraday) 101.803M
  • Beta (5Y Monthly) 12.38
  • PE Ratio (TTM) 32.52
  • EPS (TTM) 0.0200
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Jin Medical International Ltd. engages in the design, development, manufacture, and sale of wheelchair and other living aids products for people with disabilities, the elderly, and people recovering from injury. The company offers wheelchairs and wheelchair components; oxygen concentrators, bath aids, and rehabilitative devices, as well as infrastructures for shared wheelchairs and other shared health products; oxygen chambers and beauty instruments; and shampoo instruments and nano thermal therapy chambers. It operates in China, Japan, the United States, Hong Kong, Singapore, Korea, Australia, and internationally. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.

www.zhjmedical.com

269

Full Time Employees

September 30

Fiscal Year Ends

Recent News: ZJYL

View More

Performance Overview: ZJYL

Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ZJYL
16.41%
S&P 500 (^GSPC)
3.58%

1-Year Return

ZJYL
80.11%
S&P 500 (^GSPC)
8.94%

3-Year Return

ZJYL
62.58%
S&P 500 (^GSPC)
24.75%

5-Year Return

ZJYL
62.58%
S&P 500 (^GSPC)
124.42%

Compare To: ZJYL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ZJYL

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    101.80M

  • Enterprise Value

    86.65M

  • Trailing P/E

    32.52

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.33

  • Price/Book (mrq)

    3.53

  • Enterprise Value/Revenue

    3.69

  • Enterprise Value/EBITDA

    21.74

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    15.64%

  • Return on Assets (ttm)

    5.78%

  • Return on Equity (ttm)

    13.02%

  • Revenue (ttm)

    23.5M

  • Net Income Avi to Common (ttm)

    3.68M

  • Diluted EPS (ttm)

    0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    26.76M

  • Total Debt/Equity (mrq)

    40.64%

  • Levered Free Cash Flow (ttm)

    688k

Research Analysis: ZJYL

View More

Company Insights: ZJYL

Research Reports: ZJYL

View More

People Also Watch